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doi:10.1016/j.ejvs.2008.07.004Abstract Introduction: The therapeutic strategies of a mobile luminal thrombus of the des-
cending thoracic aorta with peripheral arterial embolization remain a matter of debate.
Report: We report the case of recurrent peripheral arterial embolism caused by a mobile
thrombus of the descending aorta, which was successfully treated by implanting an endovas-
cular stent graft.
Discussion: Our case demonstrates, that endovascular stent graft placement is feasible and
can be performed as an effective and minimally invasive treatment option for mobile thoracic
aortic thrombi.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
A mobile thrombus in the thoracic aorta is a rare source of
visceral, cerebral, and peripheral embolism.1 The best
management of this disease is still a matter of debate and
includes systemic anticoagulation,2 and open surgical
procedures.1,2 Among these, surgical treatment has been
used rather restrictively, mainly because operative
morbidity was still considered comparatively high.2 We
describe the case of a symptomatic thoracic aortic thrombus
which, after frustrane systematic anticoagulation, was, MD, Division of Vascular
h-Stelzmann-Straße 9, 50924
8 32498; fax: þ49 221 478
ahoo.de (T. Luebke).
ty for Vascular Surgery. Publishefinally successfully treated by means of endovascular stent
graft placement.
Report
A 47-year-old woman was admitted to a peripheral hospital
with a history of acute rest pain in both legs. A computed
tomography (CT) scan of the abdomen revealed thrombotic
occlusion of the infrarenal abdominal aorta as well as of
both iliacal arteries. A retrograde endarterectomy and
thrombectomy of the infrarenal aorta and both iliacal
arteries as well as a bilateral thrombectomy of the super-
ficial and deep femoral artery followed by patchplasty was
performed. The patient was heparinized with a systemic
dosage.
Ten days postoperatively, rest pain of both legs
occurred again. Then a transbrachial intraarteriald by Elsevier Ltd. All rights reserved.
Figure 2 Postoperative CT scan shows the stent graft with no
luminal thrombus or other luminal defect being present.
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femoral arteries. A CT-scan showed an approximately
1.5- 8-cm endoluminal mass located in the descending
thoracic aorta, 5 cm distal to the origin of the left
subclavian artery (Fig. 1). The implantation base was
sessile. After catheter guided thrombolysis with 3.3 mill.
units of urokinase a recanalization of the superficial
femoral and popliteal artery could be achieved. The
maximal thrombolytic dosage, proposing an additional
systemic effect, did not affect the aortic thrombus.
Therefore, in order to prevent further peripheral and
potentially fatal visceral embolization, we decided to
insert an endograft covering the aortic thrombus. For that
purpose, a 26 mme10 cm thoracic stent graft (EXCLUDER,
W.L. Gore & Associates, Flagstaff, AZ, USA) was used. The
final transbrachial angiogram showed excellent posi-
tioning of the stent-graft distal to the origin of the left
subclavian artery without luminal defects. The luminal
thrombus could not be visualized and no other luminal
defects were present at postoperative CT-scan control
(Fig. 2).
The peri- and postoperative course was uneventful.
Discussion
The reason for choosing endovascular repair in our case was
based on various key prepositions:
Firstly, the thrombus was located in the descending
thoracic aorta and the implantation base was sessile.
Consequently, thrombus localisation was favourable for
stent graft placement.
Secondly, although introducing the guidewire and stent
graft carries a certain risk of dislodging the thrombus, we
felt EVAR to be feasible because the thrombus was at
least 4 weeks old at the time of operation and it has
remained unchanged after systemic anticoagulation. As
a result, we could assume that the thrombus was already
partly organized, which presumably would lower the riskFigure 1 Sagittal computed tomography scans demon-
strating the mobile mural thrombus in the descending aorta.of peri- and intraoperative peripheral arterial embolism.
In addition to that, we used a left transbrachial angio-
graphic access in order to prevent further manipulation of
the thrombus and therefore to minimize the risk of
releasing an atherothrombotic fragment from the thoracic
aorta.
Thirdly, despite the young age of the patient, good long-
term results could be expected as there was no other
underlying aortic pathology present. Thus, future formation
of endoleaks or stent graft migration is very unlikely to
occur. Furthermore, experience gained from the use of
thoracic aortic stent grafts for the treatment of aneurysms
suggests that thrombus generation in a thoracic aortic stent
graft with normal configuration and high flow is extremely
rare.3
In comparison to EVAR, open surgical procedures
comprise the major drawback of a higher perioperative
morbidity and mortality.4
An endoluminal stentgraft can be used to cover the
circumscibed wall pathology or remnant thrombus material
after incomplete thrombolysis and therefore restores
physiological flow patterns in the aorta which should
prevent the development of recurrent thrombus after
thrombectomy.
With the use of anticoagulation, complete resolution or
reduction in the size of the thrombus has been reported2
but surgical thrombus removal is suggested if anti-
coagulation alone is not effective. Anticoagulation alone
can not effectively prevent recurrent embolization.
Considering the general health status, age, localisation
and dimension of the thrombus as well as the frequency
of embolic episodes, EVAR represents an effective and
minimal invasive therapy with low morbidity and
presumably good long term results in such selected
patients.
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